Basal characteristics of the prospective spanish immunotherapy registry of cardiovascular toxicity: SIR-CVT

Back

ESC Professional Premium Access

Basal characteristics of the prospective spanish immunotherapy registry of cardiovascular toxicity: SIR-CVT

Session: Cardio-oncology 4

Topic: Cardio-Oncology

Speaker: Doctor E. Zatarain-Nicolas (Madrid, ES)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Eduardo Zatarain-Nicolas

University Hospital Gregorio Maranon, Madrid (Spain)

1 presentation

0 follower

6 more presentations in this session

The prognostic significance of troponin level in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study)

Speaker: Doctor A. Kaura (London, GB)

Access

Abstract

Slides

COVID-19 and acute heart failure among patients with cancer

Speaker: Doctor M. Bergami (Bologna, IT)

Access

Abstract

Slides

Effect of 1st line treatment on aortic inflammation as assessed by 18 FDG PET/CT in patients with Hodgkin and non-Hodgkin lymphoma

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Access

Abstract

Slides

Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up

Speaker: Doctor A. Daniele (Buenos Aires, AR)

Access

Abstract

Slides

Prognostic impact of coronary artery calcifications in patients with newly diagnosed prostate cancer

Speaker: Doctor N. Stoedkilde-Joergensen (Aarhus, DK)

Access

Abstract

Slides

Access the full session

Cardio-oncology 4

Speakers: Doctor E. Zatarain-Nicolas, Doctor A. Kaura, Doctor M. Bergami, Doctor D. Terentes-Printzios, Doctor A. Daniele...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources